Symbol
CERO on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
17K shares
Security Ownership
0%

YK Bioventures Opportunities GP I, LLC ownership in CERo Therapeutics Holdings, Inc. Common Stock, $0.0001 par value per share (CERO)

2024-12-17 - YK Bioventures Opportunities GP I, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17K shares of CERo Therapeutics Holdings, Inc. Common Stock, $0.0001 par value per share (CERO). This represents 0% percent ownership of the company.